← Eichor
Study identifier: NCT06919029 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study)

Condition: Diabetes Mellitus, Type I  ·  Sponsor: National and Kapodistrian University of Athens

PhaseN/A
Planned participants30
Who can joinAll sexes, 7 Years to 17 Years
Healthy volunteersNo

About this study

The objective of this study is to evaluate glycemic control of users of the AHCL system MiniMed 780G with GS4 calibration-free sensor in children and adolescents with newly diagnosed T1D implemented directly upon T1D diagnosis in combination with continuous glucose monitoring system (CGMS) compared with those treated with MDI retrieved from historical data- in a single- arm open-label prospective observational study, assessed at 3 months. After the initial study period there will be a 3month extension phase of the study.

This description comes directly from the study's public registry record.

Talk to the study team

Christina Kanaka- Gantenbein, Professor  ·  00302132013244  ·  ckanaka@med.uoa.gr

Always discuss trial participation with your own doctor first.

Locations (1)

First Department of Pediatrics, National and Kapodistrian University of Athens, Medical School, "Aghia Sophia" Children's HospitalAthens, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06919029